Status:
COMPLETED
Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
Lead Sponsor:
Children's Hospitals and Clinics of Minnesota
Conditions:
Respiratory Distress Syndrome
Cronic Lung Disease
Eligibility:
All Genders
72+ years
Phase:
PHASE3
Brief Summary
The specific aims of this study are to evaluate the amount of high flow nasal cannula (HFNC) gas flow required to generate an equivalent positive distending pressure as that provided by nasal continuo...
Detailed Description
In the face of exogenous surfactant and use of antenatal steroids, respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in premature infants. RDS is the result of a s...
Eligibility Criteria
Inclusion
- 1\) receiving NCPAP ventilatory support at \> 72 hrs. of age and 2) requiring FiO2 21-50% on NCPAP.
Exclusion
- FiO2 \>50%, presence of pneumothorax or pleural effusion, anatomical abnormalities of the airway, lungs, or esophagus, or cyanotic congenital heart defect.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00356668
Start Date
July 1 2006
End Date
September 1 2007
Last Update
July 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States, 55404